Cerus Acquires Product Commercial Rights from BioOne
Supply Chain Editor
Cerus Corporation has signed an agreement to acquire BioOne Corporation's commercialization rights in Asia for the Intercept Blood System for platelets and plasma, subject to approval of the transaction by.....
Subscribe for Full Access!
Gain valuable sourcing and trade intelligence from our database of millions of data points spanning 20+ years!
